Lysophosphatidylcholine to stratify risk of ischemic stroke in TIA

Affiliations

¹ From the Department of Neurology and the MIND Institute (G.C.J.), University of California at Davis, Sacramento; and the Neurovascular Research Laboratory (J.M.), Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain. gcjickling@ucdavis.edu.
² From the Department of Neurology and the MIND Institute (G.C.J.), University of California at Davis, Sacramento; and the Neurovascular Research Laboratory (J.M.), Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.

Editorial

Glen C Jickling et al. Neurology. 2015.

. 2015 Jan 6;84(1):17-8.

doi: 10.1212/WNL.0000000000001100. Epub 2014 Dec 3.

¹ From the Department of Neurology and the MIND Institute (G.C.J.), University of California at Davis, Sacramento; and the Neurovascular Research Laboratory (J.M.), Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain. gcjickling@ucdavis.edu.
² From the Department of Neurology and the MIND Institute (G.C.J.), University of California at Davis, Sacramento; and the Neurovascular Research Laboratory (J.M.), Vall d'Hebron Institute of Research, Universitat Autònoma de Barcelona, Spain.

No abstract available

Comment on

Metabolomics predicts stroke recurrence after transient ischemic attack.
Jové M, Mauri-Capdevila G, Suárez I, Cambray S, Sanahuja J, Quílez A, Farré J, Benabdelhak I, Pamplona R, Portero-Otín M, Purroy F. Jové M, et al. Neurology. 2015 Jan 6;84(1):36-45. doi: 10.1212/WNL.0000000000001093. Epub 2014 Dec 3. Neurology. 2015. PMID: 25471397 Free PMC article.